Cryolife reported $38.05M in Selling and Administration Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbott ABT:US $ 2.74B 44M
Accuray ARAY:US $ 20.97M 2.98M
Atricure ATRC:US $ 62.39M 6.27M
Baxter International BAX:US $ 817M 27M
Becton, Dickinson and BDX:US $ 1.15B 83M
Boston Scientific BSX:US $ 1.16B 105M
Cardiovascular Systems CSII:US $ 46.59M 4.91M
Cryolife CRY:US $ 38.05M 1.71M
Edwards Lifesciences EW:US $ 409M 38.7M
Inogen INGN:US $ 43.07M 158K
Integra Lifesciences IART:US $ 157.99M 6.97M
Johnson & Johnson JNJ:US $ 6.23B 288M
Mesa Laboratories MLAB:US $ 27.74M 2.3M
Natus Medical BABY:US $ 42.36M 526K
Orthofix International OFIX:US $ 75.73M 2.27M
Pfizer PFE:US $ 3.2B 506M
Resmed RMD:US $ 182.4M 2.96M
Stryker SYK:US $ 1.46B 44M
Surmodics SRDX:US $ 12.85M 1.74M
Tandem Diabetes Care TNDM:US $ 80.61M 7.34M
Teleflex TFX:US $ 216.82M 12.89M
Terumo 4543:JP 70.63B 3.47B
Trinity Biotech TRIB:US 6.13M 572K